Clinical Trial Update: A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating STI-8591 in adults with advanced acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• STI-8591

Snippet

Sponsor: Zhejiang ACEA Pharmaceutical Co. Ltd. | Conditions: AML, Adult | Phase 1 | Status: RECRUITING